Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3801-3812
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3801
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3801
Table 4 Summary of evidence for medical management of intestinal Behçet’s disease
Therapy | Level(s) of published evidence |
5-ASA/sulfasalazine | Retrospective cohort study[95] |
Corticosteroids | Expert opinion, European League Against Rheumatism Recommendations[114] |
Thalidomide | Case reports[131-133] |
Azathioprine, 6-MP | Retrospective cohort studies[97,123] |
Mycophenolate | Case report[134] |
Methotrexate | Case series[135] |
Tacrolimus | Case report[136] |
Infliximab | Single arm clinical trial[102], Retrospective cohort study[104] |
Case series[101] | |
Adalimumab | Prospective, non-placebo controlled clinical trial[110] |
Etanercept | Case report[112] |
- Citation: Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behçet's disease: A review. World J Gastroenterol 2015; 21(13): 3801-3812
- URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3801.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3801